Skip to content
Poruchy spánku

Lecba Poruchy spánku

Prozkoumejte dostupnou lecbu poruchy spánku. Vse zahrnuje posouzeni nezavislym lekarem z EU, originalni leky z licencovanych lekaren a diskretni expresni doruceni.

2026-04-12 Léčba

Interested in Poruchy spánku?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Sleep disorder léčba v Evropě

Sleep disorders represent a significant and growing public health burden across the European Union. Insomnia — characterised by persistent difficulty falling asleep, staying asleep, or waking too early, with consequent daytime impairment — is estimated to affect between 10% and 30% of the adult European population. When accounting for sub-threshold sleep disturbance, the figure is considerably higher.

The consequences of inadequate sleep extend well beyond fatigue. Chronic insomnia is associated with increased risk of cardiovascular disease, metabolic disorders including type 2 diabetes, depression, anxiety, and impaired cognitive function. Occupational and road safety risks associated with sleep deprivation impose significant societal costs.

Sleep disorders exist on a spectrum. Transient or short-term insomnia, often related to stress, travel, or life events, frequently resolves without pharmacological intervention. Chronic insomnia — defined as occurring at least three nights per week for at least three months — is a recognised medical condition warranting clinical evaluation and, where appropriate, treatment.

International clinical guidelines, including those from the European Sleep Research Society, recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia. Pharmacological treatments may be appropriate for short-term management or when CBT-I is unavailable or insufficient. Prescription sleep medications include melatonin (approved for certain indications), and sedative-hypnotic agents (Z-drugs) such as zopiclone and zolpidem.

It is important that any prescription for sleep medication be accompanied by assessment for underlying causes, including sleep apnoea, depression, anxiety, or medication side effects. A qualified, independent doctor is best placed to determine the appropriate treatment pathway.

Dostupné léčby

The following medications may be available for sleep disorders through EU-registered doctors. This comparison is provided for informational purposes only.

MedicationActive IngredientClassTypical Use
Melatonin (prescription)MelatoninChronobiotic hormoneCircadian rhythm disorders, older adults with insomnia
ZopicloneZopicloneZ-drug (sedative-hypnotic)Short-term insomnia
ZolpidemZolpidem tartrateZ-drug (sedative-hypnotic)Short-term insomnia

Key distinctions:

  • Melatonin: A physiological hormone rather than a sedative. Primarily regulates circadian rhythm. EMA-approved for short-term treatment of insomnia in patients over 55, and for jet lag. Lower dependence risk than Z-drugs.
  • Zopiclone: A cyclopyrrolone that enhances GABA activity, producing sedation. Standard prescription duration is typically 2–4 weeks. Carries risks of tolerance, dependence, and morning residual sedation.
  • Zolpidem: An imidazopyridine with similar mechanism to zopiclone. Sleep-onset focused. European regulators have lowered recommended doses (particularly for women) due to next-morning impairment data.

Jak získat léčba online

Prescrivia působí jako technologický zprostředkovatel: nepředepisujeme léky, nezaměstnáváme lékaře ani neprodáváme léky. Naše platforma spojuje pacienty s nezávislými lékaři registrovanými v EU, kteří mohou provádět důvěrná online zdravotní posouzení.

Postup je následující:

  1. Vyplňte zdravotní dotazník — Answer a structured set of medical questions covering your sleep patterns, duration of difficulties, sleep environment, mental health history, current medications, and any previous treatment for sleep disorders.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a prescription sleep medication is clinically appropriate for a short-term period, the doctor may issue a prescription. If other factors indicate a different approach is warranted, the doctor will advise accordingly.

  3. Předpis a vyřízení — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The pharmacy dispenses the medication and arranges delivery to your address.

Důležité: Prescrivia nezaručuje, že bude předpis vystaven. Veškerá rozhodnutí o předepisování provádějí nezávisle kvalifikovaní odborní lékaři na základě Vašich individuálních klinických okolností. Z-drugs are controlled substances in many EU member states and are subject to strict prescribing restrictions.

Jak se srovnáváme

Prostřednictvím PrescriviaOsobní návštěva u lékaře
Dostupnost24/7 online assessmentSubject to appointment availability
Čekací dobaAssessment reviewed within hoursDays to weeks depending on location
Cestování nutnéNoYes
Rozhodnutí o předpisuMade by independent EU-registered doctorMade by your GP
Ongoing monitoringSupported via follow-up assessmentsManaged by your GP
NákladyTransparent pricing displayed upfrontVaries by country and healthcare system

Note: Sleep disorders associated with sleep apnoea, restless legs syndrome, narcolepsy, or significant psychiatric comorbidity require specialist evaluation. Prescrivia’s platform is designed for adults with primary short-term insomnia suitable for remote assessment. Long-term management of chronic insomnia should ideally involve CBT-I delivered by a qualified practitioner.

Zdroje

Lékařské informace na této stránce vycházejí z následujících zdrojů:

  • European Medicines Agency (EMA). Circadin (melatonin) — Summary of Product Characteristics. Available at: ema.europa.eu
  • Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research. 2017;26(6):675-700.
  • World Health Organization (WHO). Sleep and health — WHO Fact Sheet. who.int

Tento obsah je pravidelně přezkoumáván s ohledem na aktualizované klinické pokyny. Je poskytován pouze pro informační účely a nepředstavuje lékařské poradenství. Vždy se poraďte s kvalifikovaným zdravotnickým pracovníkem o radě týkající se Vašich individuálních zdravotních okolností.

Frequently asked questions

Mohu získat Poruchy spánku online v Evropě?
Přístup k přípravku můžete získat prostřednictvím online zprostředkovatelských platforem, které Vás spojí s nezávislými lékaři registrovanými v EU. Po vyplnění důvěrného zdravotního dotazníku lékař posoudí, zda je lék pro Vás klinicky vhodný.
Jaký je rozdíl between melatonin and zopiclone or zolpidem?
Melatonin is a hormone naturally produced by the body that regulates the sleep-wake cycle. Prescription melatonin is primarily used for circadian rhythm disturbances and jet lag, and for older adults with insomnia. Zopiclone and zolpidem are sedative-hypnotic drugs (Z-drugs) that act on GABA receptors to induce sleep. They are more potent and carry greater risk of dependence.
Jak dlouho can I take zopiclone or zolpidem?
Z-drugs such as zopiclone and zolpidem are generally recommended for short-term use only — typically 2 to 4 weeks — due to risks of tolerance, dependence, and withdrawal. European clinical guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia.
Is melatonin available without a prescription in Europe?
Melatonin's regulatory status varies across EU member states. In some countries it is available as an over-the-counter supplement; in others, including Germany and Ireland, prescription-strength melatonin requires a doctor's prescription. An independent doctor can assess what is appropriate for your situation.
What information do I need to provide for a sleep disorder assessment?
You will typically be asked about the nature of your sleep difficulties, how long they have persisted, any identified triggers, your current medications, medical history (including mental health history), and whether you have been evaluated for conditions such as sleep apnoea. This allows the reviewing doctor to make a safe clinical decision.
Prescrivia je pouze zprostředkovatelská platforma. Neposkytujeme lékařské služby, nepředepisujeme léčbu ani nevydáváme léky. Všechna lékařská rozhodnutí činí nezávislí lékaři registrovaní v EU. Všechny léky vydávají licencované lékárny v EU. Tato platforma usnadňuje spojení mezi pacienty a poskytovateli zdravotní péče.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Jste připraveni začít?

Vyplňte důvěrné zdravotní hodnocení za přibližně 3 minuty.